Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitShares OutstandingShares Outstanding
Ratios

Goldenwell Biotech (GWLL) Shares Issued (2019 - 2021)

Goldenwell Biotech's Shares Issued history spans 3 years, with the latest figure at $13675.0 for Q3 2021.

  • For Q3 2021, Shares Issued changed N/A year-over-year to $13675.0; the TTM value through Jun 2023 reached $13675.0, changed N/A, while the annual FY2022 figure was $884700.0, 862.68% up from the prior year.
  • Shares Issued reached $13675.0 in Q3 2021 per GWLL's latest filing, down from $78225.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $248904.0 in Q4 2019 to a low of $1000.0 in Q4 2020.
  • Average Shares Issued over 3 years is $71221.5, with a median of $45950.0 recorded in 2021.
  • Peak YoY movement for Shares Issued: tumbled 99.6% in 2020, then soared 971.58% in 2021.
  • A 3-year view of Shares Issued shows it stood at $248904.0 in 2019, then crashed by 99.6% to $1000.0 in 2020, then surged by 1267.5% to $13675.0 in 2021.
  • Per Business Quant, the three most recent readings for GWLL's Shares Issued are $13675.0 (Q3 2021), $78225.0 (Q2 2021), and $78225.0 (Q1 2021).